PUBLISHER: The Business Research Company | PRODUCT CODE: 1826800
PUBLISHER: The Business Research Company | PRODUCT CODE: 1826800
An intracranial aneurysm is a localized, abnormal dilation or ballooning of a blood vessel in the brain. It occurs when a blood vessel becomes weakened, often due to a combination of genetic predisposition, high blood pressure, and other risk factors such as smoking or aging.
The primary treatment approaches for intracranial aneurysms include endovascular coiling, surgical clipping, flow diverters, and other methods. Endovascular coiling is a minimally invasive procedure designed to treat intracranial aneurysms by filling the aneurysm with coils to prevent blood flow and reduce rupture risk. The product types for managing intracranial aneurysms include aneurysm therapeutic devices, embolization devices, aspiration devices, and access devices. These are utilized by various end users, including hospitals, specialty clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The intracranial aneurysm are market research report is one of a series of new reports from The Business Research Company that provides intracranial aneurysm market statistics, including intracranial aneurysm are industry global market size, regional shares, competitors with an intracranial aneurysm are market share, detailed intracranial aneurysm are market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial aneurysm are industry. This intracranial aneurysm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intracranial aneurysm market size has grown rapidly in recent years. It will grow from $1.64 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to outbreaks in emerging economies, limited treatment options available, international funding for tropical disease, focus on early diagnosis, and government vaccination campaigns.
The intracranial aneurysm market size is expected to see rapid growth in the next few years. It will grow to $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to climate change and weather variability, global health initiatives by WHO and UNICEF, emerging new therapeutics, regulatory approvals for new treatments, and health insurance expansion. Major trends in the forecast period include advancements in vector control, convergence of artificial intelligence, new antiviral agents, integration of big data in treatment strategies, and a shift to integrated disease management.
The forecast of 10.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of platinum embolization coils and neurovascular guide catheters sourced from Switzerland and Japan, thereby delaying endovascular repairs and elevating neurosurgical expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing demand for minimally invasive procedures is driving the expansion of the intracranial aneurysm market. These procedures involve medical interventions performed through small incisions or openings, offering benefits such as shorter recovery times, fewer complications, reduced pain, and minimal scarring. Their appeal lies in providing patients with safer and faster treatment options. Advances in intracranial aneurysm management have further enhanced minimally invasive procedures by enabling precise interventions that improve recovery times and surgical outcomes. For example, in 2023, the American Society of Plastic Surgeons reported a rise in cosmetic minimally invasive procedures, with numbers increasing from 23.7 million in 2022 to 25.4 million in 2023. This growing trend highlights the broader acceptance and demand for minimally invasive techniques, supporting the growth of the intracranial aneurysm market.
Companies in this market are advancing technologies such as flow diverters to address complex aneurysms effectively. Flow diverters are medical devices designed for wide-necked or challenging aneurysms, offering improved patient outcomes and reduced risks. In June 2022, Medtronic plc introduced the Pipeline Vantage with Shield Technology, a flow diverter for intracranial aneurysms. This device features synthetic phosphorylcholine surface technology for enhanced hemocompatibility, reducing thrombogenicity. It includes advanced designs with 48 or 64 cobalt chromium wires for better deliverability, endothelial growth, and optimized pore density to improve aneurysm occlusion rates. Its innovative delivery system also allows easier deployment and repositioning, highlighting its safety and efficacy in aneurysm treatment.
In May 2023, Stryker Corporation acquired Cerus Endovascular Limited to strengthen its neurovascular portfolio. This acquisition included Cerus's CE-marked products such as the Contour Neurovascular System and Neqstent Coil Assisted Flow Diverter, which cater to the increasing demand for efficient, one-and-done intrasaccular aneurysm therapy. Cerus Endovascular Limited specializes in developing innovative medical devices for intracranial aneurysm treatment, and this acquisition enhances Stryker's position in the neurovascular treatment market.
Major players in the intracranial aneurysm market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, Integra LifeSciences Holdings Corporation, MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., B. Braun SE, Phenox GmbH, Rapid Medical Ltd., Balt Group, Sim&Cure, Acandis GmbH & Co. KG, Codman Neuro, Microbot Medical Inc., EndoStream Medical Ltd., NeuroSigma Inc., Shape Memory Medical Inc., Evasc Neurovascular Enterprises ULC.
North America was the largest region in the intracranial aneurysm market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intracranial aneurysm report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the intracranial aneurysm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intracranial aneurysm market consists of sales of flow diverter devices, embolization coils, neurovascular stents, intracranial balloons, aneurysm clips, and monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intracranial Aneurysm Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on intracranial aneurysm market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intracranial aneurysm ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intracranial aneurysm market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.